Apolipoprotein AI Monoklonaler Antikörper
Apolipoprotein AI Monoklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Maus / IgG2b
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1C9G5
Kat-Nr. : 66206-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66206-1-PBS bindet in WB, IHC, IF/ICC, FC (Intra), Indirect ELISA Apolipoprotein AI und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus | 
| Wirt / Isotyp | Maus / IgG2b | 
| Klonalität | Monoklonal | 
| Typ | Antikörper | 
| Immunogen | Apolipoprotein AI fusion protein Ag21920 | 
| Vollständiger Name | apolipoprotein A-I | 
| Berechnetes Molekulargewicht | 31 kDa | 
| Beobachtetes Molekulargewicht | 26-28 kDa | 
| GenBank-Zugangsnummer | BC005380 | 
| Gene symbol | APOA1 | 
| Gene ID (NCBI) | 335 | 
| Konjugation | Unkonjugiert | 
| Form | Liquid | 
| Reinigungsmethode | Protein-A-Reinigung | 
| Lagerungspuffer | PBS only | 
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. | 
Hintergrundinformationen
ApoA1 is a major protein component of high density lipoproteins (HDL) which is associated with reversed cholesterol transport, lipid/cholesterol binding, lecithin/cholesterol acyltransferase (LCAT) activation and specific receptors binding. It is synthesized in the liver and small intestine. Defects of ApoA1 cause low HDL level and systemic non-neuropathic amyloidosis. Serum concentration of ApoA1 is inversely related to the risk of developing atherosclerosis. This antibody was generated against the C-terminal region of human ApoA1.













